(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics Clinical Chemistry >  2015 Clinical Chemistry and Immunodiagnostics Market: Confronting Regulatory Uncertainty and Intensifying Competition--Supplier Shares and Market Segment Forecasts for 100 Tests, Innovative Instrumentation, Competitive Strategies

2015 Clinical Chemistry and Immunodiagnostics Market: Confronting Regulatory Uncertainty and Intensifying Competition--Supplier Shares and Market Segment Forecasts for 100 Tests, Innovative Instrumentation, Competitive Strategies




Complete report PDF $37,500, DataPack (500 tables) $23,500. The report is available by geographic region, country, section, market segment, test category, and individual assay (contact reports@vpgcorp.com or +1 212 564 2838).

“2015 Global Clinical Chemistry and Immunodiagnostics Market” is VPGMarketResearch.com new strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future trends in the U.S., Europe and Asia; provides specimen, test and sales forecast; estimates sales and market shares of major suppliers; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.

Rationale

Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.  Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology.  This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Geographic Coverage

Europe

France

Germany

Italy
 
Japan

Spain

UK
 
USA

Global Market Overview

- Estimates of facilities performing clinical chemistry
and immunodiagnostic tests by country.

- Test volume and sales projections by country.

Market Segmentation Analysis

- Comprehensive review of the market
dynamics, trends, structure, size, growth,
and key suppliers, by country.

- Test volume and sales forecasts for over 100 clinical chemistry,
TDM, endocrine, cancer, immunoprotein and abused drug assays,
by country and market segment:

    
Market Segmentation 

  Centralized Testing 

  - Hospitals
  - Commercial/Private Laboratories

  POC/Decentralized Testing 

  - Ambulatory Care Centers
  - Birth Centers
  - Cancer Clinics
  - Emergency Departments
  - ICUs/CCUs
  - Nursing Homes
  - Operating Recovery Suites
  - Physician Offices/Group Practices
  - Surgery Centers

Home/Self Testing

Test Categories

- Clinical Chemistry

- Therapeutic Drug Monitoring

- Endocrine Function

- Drugs of Abuse

- Immunoproteins 

- Tumor Markers and Special Chemistry

Individual Tests Analyzed in the Report

Routine Clinical Chemistry

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total,
BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus, Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.

Therapeutic Drug Monitoring (TDM)

Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam,
Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus,
Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.

Endocrine Function

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,
Prolactin, T3, T3 Uptake,  Free T3, T4, Free T4, TBG, Testosterone,
Thyroglobulin Ab,  TPO Ab, TSH.

Tumor Markers and Special Chemistry

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),
Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,
PAP, PSA, Thyroglobulin, Vitamin B-12.

Immunoproteins

C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,
Immunofixation, Prealbumin, Protein Electrophoresis.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,
LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP),
Propoxyphene, Tricyclic Antidepressants.

Current and Emerging Products

- Analysis of current and emerging clinical chemistry
and immunodiagnostic tests.

- Review of current instrumentation technologies, and feature comparison
of high-, medium-, and low-volume/POC analyzers.

Technology Review

- Assessment of current and emerging
technologies, and their potential market applications.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Strategic Recommendations

- New product development opportunities
with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.  The companies analyzed in the report include: 

   - Abbott
   - AdnaGen
   - Agilent Technologies         
   - Beckman Coulter/Danaher
   - Biomedical Diagnostics
   - BioMerieux
   - Bio-Rad             
   - DiaSorin
   - Eiken
   - Fujirebio
   - Instrumentation Laboratory
   - Kyowa Medex
   - Matritech/Alere
   - Ortho-Clinical Diagnostics
   - Quest Diagnostics
   - Roche
   - Siemens
   - Sysmex
   - Thermo Fisher
   - Tosoh
   - Wako
   - Wallac

Contains 1200 pages and 500 tables



To order sections of this report, contact Client Services


     
   
Local PDF: $37500.00
Other Formats: Global PDF, DataPack
   
   
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X